tobramycin has been researched along with flucytosine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (35.29) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 5 (29.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Fieker, DH; McHenry, MC | 1 |
| McAllister, TA | 1 |
| Blair, AD; Christopher, TG; Cutler, RE; Forrey, AW | 1 |
| Calvin, S; Luis, ES; McDaid, T; Potter, D; Powell, D | 1 |
| Chen, JS; Liang, HP; Lu, LR; Sheng, ZY; Shi, ZG; Yao, YM; Yu, Y; Zhou, BT | 1 |
| Burkert, M; Fuhr, HG; Mertelsmann, R | 1 |
| Bai, X; Gao, F; Gong, Y; Han, J; Hu, D; Li, J; Xu, J; Xu, M; Yang, X; Zhang, X; Zhu, H; Zhu, L | 1 |
2 review(s) available for tobramycin and flucytosine
| Article | Year |
|---|---|
Newer antibacterial and antimycotic drugs. Critical appraisal.
Topics: Amikacin; Anti-Bacterial Agents; Antifungal Agents; Cephalosporins; Clindamycin; Flucytosine; Humans; Imidazoles; Penicillins; Rifampin; Spectinomycin; Sulfamethoxazole; Tetracyclines; Tobramycin; Trimethoprim | 1978 |
Recent advances in antibiotics.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Antitubercular Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Flucytosine; Gentamicins; Metronidazole; Penicillins; Plasmids; Sisomicin; Tobramycin | 1976 |
15 other study(ies) available for tobramycin and flucytosine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Hemodialyzer clearances of gentamicin, kanamycin, tobramycin, amikacin, ethambutol, procainamide, and flucytosine, with a technique for planning therapy.
Topics: Amikacin; Creatinine; Drug Therapy; Ethambutol; Flucytosine; Gentamicins; Humans; Kanamycin; Models, Biological; Pentetic Acid; Pharmaceutical Preparations; Procainamide; Renal Dialysis; Tobramycin | 1976 |
Septicaemia.
Topics: Cefazolin; Cephaloridine; Cephalothin; Cephradine; Clindamycin; Drug Resistance, Microbial; Flucytosine; Gentamicins; Humans; Lincomycin; Metronidazole; Sepsis; Shock, Septic; Tobramycin | 1975 |
Peritonitis in children undergoing continuous ambulatory peritoneal dialysis.
Topics: Adolescent; Adult; Amphotericin B; Anti-Bacterial Agents; Cefazolin; Child; Child, Preschool; Drug Therapy, Combination; Female; Flucytosine; Humans; Infant; Male; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Tobramycin | 1985 |
Influence of selective decontamination of the digestive tract on cell-mediated immune function and bacteria/endotoxin translocation in thermally injured rats.
Topics: Animals; Anti-Bacterial Agents; Bacterial Translocation; Burns; Cell Division; Cells, Cultured; Colistin; Digestive System; Disease Models, Animal; Endotoxins; Flucytosine; Immunity, Cellular; Immunosuppression Therapy; Interleukin-2; Intestines; Lymphocyte Subsets; Rats; Rats, Sprague-Dawley; Spleen; Tobramycin | 1997 |
Antimycotic combination therapy in patients with acute myeloblastic leukemia.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Flucytosine; Humans; Leukemia, Myeloid, Acute; Middle Aged; Mycoses; Tobramycin; Vancomycin | 1989 |
Selective decontamination of the digestive tract ameliorates severe burn-induced insulin resistance in rats.
Topics: Animals; Anti-Infective Agents; Blotting, Western; Burns; Colistin; Cytokines; Flucytosine; Gastrointestinal Microbiome; Gastrointestinal Tract; Glucose Tolerance Test; I-kappa B Kinase; Insulin Receptor Substrate Proteins; Insulin Resistance; Lipopolysaccharides; Male; MAP Kinase Kinase 4; Permeability; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Tobramycin | 2015 |